• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十氢异喹啉的稠环结构作为严重急性呼吸综合征3C样蛋白酶抑制剂的新型骨架。

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors.

作者信息

Shimamoto Yasuhiro, Hattori Yasunao, Kobayashi Kazuya, Teruya Kenta, Sanjoh Akira, Nakagawa Atsushi, Yamashita Eiki, Akaji Kenichi

机构信息

Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.

Department of Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Sakyo-ku, Kyoto 606-0823, Japan.

出版信息

Bioorg Med Chem. 2015 Feb 15;23(4):876-90. doi: 10.1016/j.bmc.2014.12.028. Epub 2014 Dec 20.

DOI:10.1016/j.bmc.2014.12.028
PMID:25614110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7111320/
Abstract

The design and evaluation of a novel decahydroisoquinolin scaffold as an inhibitor for severe acute respiratory syndrome (SARS) chymotrypsin-like protease (3CL(pro)) are described. Focusing on hydrophobic interactions at the S2 site, the decahydroisoquinolin scaffold was designed by connecting the P2 site cyclohexyl group of the substrate-based inhibitor to the main-chain at the α-nitrogen atom of the P2 position via a methylene linker. Starting from a cyclohexene enantiomer obtained by salt resolution, trans-decahydroisoquinolin derivatives were synthesized. All decahydroisoquinolin inhibitors synthesized showed moderate but clear inhibitory activities for SARS 3CL(pro), which confirmed the fused ring structure of the decahydroisoquinolin functions as a novel scaffold for SARS 3CL(pro) inhibitor. X-ray crystallographic analyses of the SARS 3CL(pro) in a complex with the decahydroisoquinolin inhibitor revealed the expected interactions at the S1 and S2 sites, as well as additional interactions at the N-substituent of the inhibitor.

摘要

本文描述了一种新型十氢异喹啉支架作为严重急性呼吸综合征(SARS)类胰凝乳蛋白酶样蛋白酶(3CL(pro))抑制剂的设计与评估。通过关注S2位点的疏水相互作用,十氢异喹啉支架的设计是将基于底物的抑制剂的P2位点环己基通过亚甲基连接基连接到P2位置α-氮原子处的主链上。从通过盐析拆分得到的环己烯对映体出发,合成了反式十氢异喹啉衍生物。所有合成的十氢异喹啉抑制剂对SARS 3CL(pro)均表现出中等但明确的抑制活性,这证实了十氢异喹啉的稠环结构可作为SARS 3CL(pro)抑制剂的新型支架。SARS 3CL(pro)与十氢异喹啉抑制剂复合物的X射线晶体学分析揭示了在S1和S2位点的预期相互作用,以及抑制剂N-取代基处的额外相互作用。

相似文献

1
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors.十氢异喹啉的稠环结构作为严重急性呼吸综合征3C样蛋白酶抑制剂的新型骨架。
Bioorg Med Chem. 2015 Feb 15;23(4):876-90. doi: 10.1016/j.bmc.2014.12.028. Epub 2014 Dec 20.
2
Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.评估非关键部位取代基和弹头与十氢异喹啉支架结合作为 SARS 3CL 蛋白酶抑制剂。
Bioorg Med Chem. 2019 Jan 15;27(2):425-435. doi: 10.1016/j.bmc.2018.12.019. Epub 2018 Dec 12.
3
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.基于与病毒蛋白酶分子相互作用的抗 SARS-CoV 药物的设计与评估。
Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920.
4
Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor.评价作为新型 SARS 3CL 蛋白酶抑制剂的八氢异喹啉骨架。
Bioorg Med Chem. 2020 Feb 15;28(4):115273. doi: 10.1016/j.bmc.2019.115273. Epub 2019 Dec 30.
5
Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold.从肽模拟物到氮杂十氢化萘支架开发SARS 3CL蛋白酶抑制剂的结构基础。
Biopolymers. 2016 Nov 4;106(4):391-403. doi: 10.1002/bip.22773.
6
Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.针对严重急性呼吸综合征3CL蛋白酶的强效酰苯胺类抑制剂的发现。
J Med Chem. 2005 Jun 30;48(13):4469-73. doi: 10.1021/jm050184y.
7
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors.严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒3C样蛋白酶抑制剂的鉴定、合成与评估。
Bioorg Med Chem. 2016 Jul 1;24(13):3035-3042. doi: 10.1016/j.bmc.2016.05.013. Epub 2016 May 12.
8
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors.5-磺酰基异吲哚酮衍生物作为严重急性呼吸综合征冠状病毒3C样蛋白酶抑制剂的合成、修饰及对接研究
Bioorg Med Chem. 2014 Jan 1;22(1):292-302. doi: 10.1016/j.bmc.2013.11.028. Epub 2013 Nov 21.
9
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors.强效SARS-CoV 3CL(蛋白酶)抑制剂的设计、合成及生物学评价的新进展
Bioorg Med Chem Lett. 2009 May 15;19(10):2722-7. doi: 10.1016/j.bmcl.2009.03.118. Epub 2009 Mar 28.
10
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.一种从食用褐藻裙带菜中分离得到的 SARS-CoV 3CL(pro) 抑制剂——藻酸双酯钠。
Bioorg Med Chem. 2013 Jul 1;21(13):3730-7. doi: 10.1016/j.bmc.2013.04.026. Epub 2013 Apr 22.

引用本文的文献

1
Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (M).阿佐连接的咪唑并[4,5-b]吲哚支架对 COVID-19 主蛋白酶(M)的合成及计算机抑制作用研究。
Sci Rep. 2024 May 6;14(1):10419. doi: 10.1038/s41598-024-57795-4.
2
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review.SARS-CoV 和 SARS-CoV-2 主要蛋白酶的结构与功能及其抑制作用:全面综述。
Eur J Med Chem. 2023 Nov 15;260:115772. doi: 10.1016/j.ejmech.2023.115772. Epub 2023 Aug 28.
3
P Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the class.

本文引用的文献

1
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings.利用虚拟筛选和高通量筛选鉴定新型药物支架以抑制SARS-CoV 3-糜蛋白酶样蛋白酶
Bioorg Med Chem. 2014 Jan 1;22(1):167-77. doi: 10.1016/j.bmc.2013.11.041. Epub 2013 Dec 1.
2
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors.5-磺酰基异吲哚酮衍生物作为严重急性呼吸综合征冠状病毒3C样蛋白酶抑制剂的合成、修饰及对接研究
Bioorg Med Chem. 2014 Jan 1;22(1):292-302. doi: 10.1016/j.bmc.2013.11.028. Epub 2013 Nov 21.
3
Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.
人γ冠状病毒3C/3CL蛋白酶抑制剂设计中的P谷氨酰胺等排体
RSC Chem Biol. 2023 Jun 21;4(8):533-547. doi: 10.1039/d3cb00075c. eCollection 2023 Aug 3.
4
Exploring the Targets of Novel Corona Virus and Docking-based Screening of Potential Natural Inhibitors to Combat COVID-19.探索新型冠状病毒的靶点并基于对接筛选潜在的天然抑制剂以对抗COVID-19
Curr Top Med Chem. 2022;22(29):2410-2434. doi: 10.2174/1568026623666221020163831.
5
Synthesis of pyrazolo[5',1':2,3]imidazo[1,5-]quinazolin-6(5)-ones and molecular docking study of their affinity against the COVID-19 main protease.吡唑并[5',1':2,3]咪唑并[1,5 - ]喹唑啉 - 6(5) - 酮的合成及其对新型冠状病毒主要蛋白酶亲和力的分子对接研究
RSC Adv. 2022 Jul 8;12(30):19579-19589. doi: 10.1039/d2ra03179e. eCollection 2022 Jun 29.
6
Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an approach.几种香豆素衍生物及其钯(II)配合物作为严重急性呼吸综合征冠状病毒2主要蛋白酶的潜在抑制剂,一种方法。
RSC Adv. 2020 Sep 23;10(58):35099-35108. doi: 10.1039/d0ra07062a. eCollection 2020 Sep 21.
7
Synthesis, crystal structure, DFT and molecular docking studies of N-acetyl-2,4-[diaryl-3-azabicyclo[3.3.1]nonan-9-yl]-9-spiro-4'-acetyl-2'-(acetylamino)-4',9-dihydro-[1',3',4']-thiadiazoles: A potential SARS-nCoV-2 Mpro (COVID-19) inhibitor.N-乙酰基-2,4-[二芳基-3-氮杂双环[3.3.1]壬烷-9-基]-9-螺-4'-乙酰基-2'-(乙酰氨基)-4',9-二氢-[1',3',4']-噻二唑的合成、晶体结构、密度泛函理论及分子对接研究:一种潜在的严重急性呼吸综合征冠状病毒2主蛋白酶(COVID-19)抑制剂
J Mol Struct. 2022 Jul 5;1259:132747. doi: 10.1016/j.molstruc.2022.132747. Epub 2022 Mar 2.
8
A Stochastic SEIRS Epidemic Model with Infection Forces and Intervention Strategies.一个具有感染动力和干预策略的随机 SEIRS 传染病模型。
J Healthc Eng. 2022 Jan 10;2022:4538045. doi: 10.1155/2022/4538045. eCollection 2022.
9
Perspectives on SARS-CoV-2 Main Protease Inhibitors.对 SARS-CoV-2 主要蛋白酶抑制剂的观点。
J Med Chem. 2021 Dec 9;64(23):16922-16955. doi: 10.1021/acs.jmedchem.1c00409. Epub 2021 Nov 19.
10
A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics.基于蛋白质动力学分析指导的基于活性的化合物库筛选构建高亲和力SARS-CoV-2 Mpro抑制剂蓝图
ACS Pharmacol Transl Sci. 2021 Mar 16;4(3):1079-1095. doi: 10.1021/acsptsci.0c00215. eCollection 2021 Jun 11.
利用基于荧光素酶的生物传感器评估中东呼吸综合征冠状病毒木瓜蛋白酶样和 3C 样蛋白酶的活性和抑制作用。
J Virol. 2013 Nov;87(21):11955-62. doi: 10.1128/JVI.02105-13. Epub 2013 Aug 28.
4
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study.新型二肽型 SARS-CoV 3CL 蛋白酶抑制剂的设计、合成与生物评价:构效关系研究。
Eur J Med Chem. 2013 Jul;65:436-47. doi: 10.1016/j.ejmech.2013.05.005. Epub 2013 May 20.
5
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.一种从食用褐藻裙带菜中分离得到的 SARS-CoV 3CL(pro) 抑制剂——藻酸双酯钠。
Bioorg Med Chem. 2013 Jul 1;21(13):3730-7. doi: 10.1016/j.bmc.2013.04.026. Epub 2013 Apr 22.
6
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease.新出现的类SARS冠状病毒HCoV-EMC也有一个“阿喀琉斯之踵”:目前针对一种类3C蛋白酶的有效抑制剂。
Protein Cell. 2013 Apr;4(4):248-50. doi: 10.1007/s13238-013-2841-3.
7
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.发现、合成及基于结构的优化一系列 N-(叔丁基)-2-(N-芳基氨基)-2-(吡啶-3-基)乙酰胺(ML188),作为强效非共价小分子抑制剂,针对严重急性呼吸综合征冠状病毒(SARS-CoV)3CL 蛋白酶。
J Med Chem. 2013 Jan 24;56(2):534-46. doi: 10.1021/jm301580n. Epub 2013 Jan 3.
8
Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases.基于腈的广谱拟肽冠状病毒 3C 样蛋白酶抑制剂的设计、合成与晶体学分析。
Eur J Med Chem. 2013 Jan;59:1-6. doi: 10.1016/j.ejmech.2012.10.053. Epub 2012 Nov 7.
9
JLigand: a graphical tool for the CCP4 template-restraint library.JLigand:一种用于CCP4模板约束库的图形工具。
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):431-40. doi: 10.1107/S090744491200251X. Epub 2012 Mar 17.
10
Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.基于结构的 SARS 3CL 蛋白酶抑制剂的肽模拟物的设计、合成与评价。
J Med Chem. 2011 Dec 8;54(23):7962-73. doi: 10.1021/jm200870n. Epub 2011 Nov 9.